IgA Monoclonal Gammopathy of Undetermined Significance
1 clinical trials · Condition
◉ Watch IgA Monoclonal Gammopathy of Undetermined Significance
| Record | Firm | Date |
|---|---|---|
| Rifaximin Versus No Intervention for the Treatment of IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined Significance (NCT07209371) | Fred Hutchinson Cancer Center | 2026-01-22 |
Track IgA Monoclonal Gammopathy of Undetermined Significance automatically
Every clearance here is in the API, with alerts when new ones post.